Up-regulation of CacyBP/SIP during rat breast cancer development

Breast Cancer

Volumn 21, Issue 3, 2014, Pages 350-357

  Kilańczyk, Ewa ^a   Gwoździński, Krzysztof ^b   Wilczek, Ewa ^c   Filipek, Anna ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Breast cancer; CacyBP SIP; DMBA induced breast cancer model; Catenin

Indexed keywords

BETA CATENIN; CALCYCLIN BINDING PROTEIN; MESSENGER RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CACYBP PROTEIN, RAT; CTNNB1 PROTEIN, RAT; SIGNAL PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CATENIN GENE; BREAST CARCINOGENESIS; CACYBP GENE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BETA CATENIN; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84901308168     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-012-0399-1     Document Type: Article

References (26)

1. Filipek A, Wojda U. p30, a novel protein target of mouse calcyclin (S100A6). Biochem J. 1996;1:585-7.
2. Schneider G, Filipek A. S100A6 binding protein and Siah-1 interacting protein (CacyBP/SIP): spotlight on properties and cellular function. Amino Acids. 2011;41:773-80.
3. Kilanczyk E, Filipek S, Jastrzȩbska B, Filipek A. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. Biochem Biophys Res Commun. 2009;380:54-9.
4. Kilanczyk E, Filipek S, Filipek A. ERK1/2 is dephosphorylated by a novel phosphatase-CacyBP/SIP. Biochem Biophys Res Commun. 2011;404:179-83.
5. Schneider G, Nieznanski K, Kilanczyk E, Bieganowski P, Kuznicki J, Filipek A. CacyBP/SIP interacts with tubulin in neuroblastoma NB2a cells and induces formation of globular tubulin assemblies. Biochim Biophys Acta. 2007;1773:1628-36.
6. Schneider G,Nieznanski K, Jozwiak J, Slomnicki LP, Redowicz MJ, Filipek A. Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim Biophys Acta. 2010;1803:1308-17.
7. Au KW, Kou CY, Woo AY, Chim SS, Fung KP, Cheng CH. Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J Cell Biochem. 2006;98:555-66. (Pubitemid 43727175)
8. Lou JR, Zhang XX, Zheng J, Ding WQ. Transient metals enhance cytotoxicity of curcumin: potential involvement of the NF-kappaB and mTOR signaling pathways. Anticancer Res. 2010;30:3249-55.
9. Chen X, Han G, Ziai H, Hang F, Wang J, Li X, et al. Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology. 2008;8:470-7.
10. Zhai H, Shi Y, Jin H, Li Y, Lu Y, Chen X, et al. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J Histochem Cytochem. 2008;56:765-72. (Pubitemid 351991089)
11. Chen X, Mo P, Li X, Zheng P, Zhao L, Xue Z, et al. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol Carcinog. doi:10.1002/mc.20737.
12. Sun S, Ning X, Liu J, Liu L, Chen Y, Han S, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun. 2007;356:864-71. (Pubitemid 46529373)
13. Ghosh D, Yu H, Tan XF, Lim TK, Zubaidah RM, Tan HT, et al. Identification of key players for colorectal cancer metastasis by iTRAQ™ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. J Proteome Res. 2011;10:4373-87.
14. Kilanczyk E, Wasik U, Filipek A. CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells. Biochem Cell Biol. 2012;90:558-64.
15. Nie F, Yu XL, Wang XG, Tang YF, Wang LL, Ma L. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer. Int J Oncol. 2010;37:1261-9.
16. Wang N, Ma Q, Wang Y, Ma G, Zhai H. CacyBP/SIP expression is involved in the clinical progression of breast cancer. World J Surg. 2010;34:2545-52.
17. Escrich E. Validity of the DMBA-induced mammary cancer model for the study of human breast cancer. Int J Biol Markers. 1987;2:197-206.
18. Barros AC, Muranaka EN, Mori LJ. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene. Rev Hosp Clin Fac Med Sao Paulo. 2004;59:257-61.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
20. Castaño Z, Tracy K, McAllister SS. The tumor macroenvironment and systemic regulation of breast cancer progression. Int J Dev Biol. 2011;55:889-97.
21. Imamura T, Hikita A, Inoue Y. The roles of TGF-b signaling in carcinogenesis and breast cancer metastasis. Breast Cancer. 2011. doi:10.1007/s12282-011-0321-2.
22. Ning X, Sun S, Hong L, Liang J, Liu L, Han S, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res. 2007;5:1254-62.
23. Fuchs SY, Ougolkov AV, Spielgelman VS, Minamoto T. Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle. 2005;4:1522-39.
24. Polakis P. The many ways of WNT in cancer. Curr Opin Genet Dev. 2007;17:45-51. (Pubitemid 46109296)
25. Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett. 1995;90:43-50.
26. Rajabi H, Ahmad R, Jin C, Kosugi M, Alam M, Joshi MD, et al. MUC1-C oncoprotein induces TCF7L2 activation and promotes cyclin D1 expression in human breast cancer cells. J Biol Chem. 2012. doi:10.1074/jbc.M111.323311.